semaglutide cardiovascular outcomes trial Semaglutides Are Poised to Remake Chronic Kidney Disease Care SOUL (Semaglutide cardiOvascular oUtcomes triaL)

Gastrointestinal side effects and high out of pocket costs have been associated with discontinuation, while being older and having diabetes are associated with longer-term maintenance of these medications

Whilst the development of GLP-1 receptor agonists was historically inspired by peptides found in Gila monster saliva, semaglutide itself is a synthetic pharmaceutical product based on human GLP-1, not lizard venom

Choosing the right therapy depends on affordability, availability, and personal health goals

Otros efectos secundarios Como hay receptores de GLP-1 en el corazn, puede producirse un aumento de la frecuencia cardaca durante el tratamiento con semaglutida